Role of the nurse immuniser in implementing and maintaining the National Human Papillomavirus 'Cervical Cancer' vaccine rollout through a school-based program in Victoria
Helen Kent, Margaret E Heffernan, Julie Silvers, Elya Moore, Suzanne M Garland
Sexual Health | CSIRO PUBLISHING | Published : 2010
MEH has received travel support from CSL and GlaxoSmithKline (GSK) to attend two international HPV conferences. SMG has received advisory board fees and grant support from CSL and GSK, and lectures fees from Merck and GSK; in addition, she has received funding through her institution to conduct HPV vaccine studies for MSD and GSK.